John E. Berriman

Insider Reports History

Location
Cambridge, MA
Signature
/s/ John Berriman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John E. Berriman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Autolus Therapeutics plc Director Ordinary Shares 136,331 18 Mar 2026 Direct

Insider Reports Filed by John E. Berriman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AUTL Autolus Therapeutics plc 18 Mar 2026 0 $0 3 Director 18 Mar 2026, 19:51